Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
Context Therapeutics Inc.
BioNTech SE
BioNTech SE
Seagen Inc.
Astellas Pharma Inc
Endocyte
Celgene
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
INSYS Therapeutics Inc
Alaunos Therapeutics